Oxaliplatin-induced painful neuropathy--flicker of hope or hopeless pain?
Stengel
Maike
M
Sektion Neurologische Schmerzforschung und - therapie, Klinik für Neurologie, Christian-Albrechts-Universität Kiel, Schittenhelmstr. 10, 24105 Kiel, Germany.
Baron
Ralf
R
D000970:Antineoplastic Agents / Q000009:adverse effects*; D042241:Early Diagnosis; D005727:Ganglia, Spinal / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D006930:Hyperalgesia / Q000139:chemically induced / Q000150:complications / Q000503:physiopathology; D009410:Nerve Degeneration / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology; D009437:Neuralgia / Q000139:chemically induced* / Q000175:diagnosis* / Q000517:prevention & control; D018696:Neuroprotective Agents / Q000627:therapeutic use; D009944:Organoplatinum Compounds / Q000009:adverse effects*; D000077150:Oxaliplatin; D010525:Peripheral Nerves / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced* / Q000175:diagnosis* / Q000517:prevention & control; D012307:Risk Factors
D000970:Antineoplastic Agents; D018696:Neuroprotective Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin